Studies in AML also demonstrate that IGFBP2 supports the activity of hematopoietic stem cells (HSCs) and promotes the proliferation of AML cells by suppressing PTEN expression and activating Akt [42, 54]. Here, AKT1 is linked to acute myeloid leukemia.